| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10486105 | Value in Health | 2015 | 7 Pages |
Abstract
Prospective benefit-risk monitoring can be used to determine net favorability of a new drug in electronic health care data. In three examples, existing BRA metrics produced qualitatively similar results but differed with respect to alert generation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Joshua J. PharmD, ScD, Katsiaryna PharmD, MS, Mehdi PhD, Niteesh K. MD, PhD, Diane P. PhD, Kristijan H. PhD, James R. BA, BS, Sebastian MD, ScD,